When was CDI Labs founded?

CDI Labs was founded in 2001 and raised its 1st funding round 9 years after it was founded.

Where is CDI Labs located?

CDI Labs is headquartered in Mayaguez, Puerto Rico. It is registered at 12 W MENDEZ VIGO ST 1, SECOND FLOOR, MAYAGUEZ, PUERTO RICO 00680.

Is CDI Labs a funded company?

CDI Labs is a funded company, having raised a total of $2.1M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 18, 2010.

When was the latest funding round of CDI Labs?

CDI Labs' latest funding was a $***** Seed round on Jan 09, 2023, with participation from 1 investor.

Where does CDI Labs rank among its competitors?

CDI Labs ranks 2nd amongst 11 active competitors, of which 3 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was OmniAb, which secured $30M in Aug, 2025.

Who are the top competitors of CDI Labs?

CDI Labs' top competitors include Araris Biotech, OmniAb and Single Cell Technology. Among them, OmniAb secured the most recent funding round in August, 2025.

CDI Labs - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of products and services for autoantibody detection and profiling. The company offers HuProt array that consists of unique human proteins, isoform variants, and protein fragments that cover genes for human autoantibody seromics discovery, protein-protein interactions, target ID of unknown binders, and antibody specificity.

Website: www.cdilabs.com/
Social
Email ID: *****@cdilabs.com
Phone Number: +1 **********
Registered Address: 12 W MENDEZ VIGO ST 1, SECOND FLOOR, MAYAGUEZ, PUERTO RICO 00680

Key Metrics

Founded Year

2001

Location

Mayaguez, Puerto Rico

Stage

Seed

Total Funding

$2.1M in 6 rounds

Latest Funding Round

Seed, Jan 09, 2023, $*****

Investors

Broadoak Capital Partners & 1 more

Ranked

2^nd among 11 active competitors

Similar Companies

Araris Biotech & 10 more

View CDI Labs' full profile

CDI Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CDI LABORATORIES, INC. CIN: 151393593 , United States, Active	Jan 14, 2019	$1M - $5M (As on Jan 15, 2021)	-	-

CDI Labs has raised a total funding of $2.1M over 6 rounds. Its first funding round was on May 18, 2010. Its latest funding round was a Seed round on Jan 09, 2023 for $*****. 1 investor participated in its latest round. CDI Labs has 2 institutional investors.

Here is the list of recent funding rounds of CDI Labs:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 09, 2023	8600987	Seed	6238431	3605416	1692439	4824901
Jan 15, 2021	5174187	Seed	7906931	4455707	5878838	3895751
Sep 01, 2016	7336870	Grant (prize money)	2775146	8078714	5546191	HHS

Access funding benchmarks and valuations. Sign up today!

View details of CDI Labs's funding rounds and investors

The founders of CDI Labs are Ignacio Pino, Heng Zhu, Jef Boeke and Seth Blackshaw. Barney Saunders is the CEO of CDI Labs.

Here are the details of CDI Labs' key team members:

Ignacio Pino: Co-Founder of CDI Labs.
Heng Zhu: Co-Founder of CDI Labs.
Jef Boeke: Co-Founder of CDI Labs.
Seth Blackshaw: Co-Founder of CDI Labs.
Barney E Saunders: CEO of CDI Labs.

View details of CDI Labs's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CDI Labs include Araris Biotech, OmniAb and Single Cell Technology. Here is the list of Top 10 competitors of CDI Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Araris Biotech 2019, Zurich (Switzerland), Acquired	Developer of novel antibody-drug conjugate linker technology	$40.8M	Pureos Bioventures, 4Bio Capital & 8 others	59/100
2nd	CDI Labs 2001, Mayaguez (Puerto Rico), Seed	Provider of products and services for autoantibody detection and profiling	$2.1M	Broadoak Capital Partners, HHS	39/100
3rd	OmniAb 2012, Palo Alto (United States), Public	Therapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies	-	-	38/100
4th	Single Cell Technology 2008, San Jose (United States), Seed	Pioneering antibody discovery platform delivering actionable leads through comprehensive data capture	$2.46M	-	33/100
5th	RevMAb Biosciences 2012, San Francisco (United States), Series A	Providing antibodies and custom services based on its proprietary antibody generation method.	$6.64M	-	33/100
6th	BiCell Scientific 2017, Scottsdale (United States), Unfunded	Validated antibodies and custom antibody services for biomedical research	-	-	29/100
7th	AbCheck 2009, Pilsen (Czech Republic), Acquired	Developer of human therapeutic antibodies	-	-	26/100
8th	AMC Science 2024, Seoul (South Korea), Unfunded	Developer of therapeutic technologies focused on oncology, immunology, and ophthalmology	-	-	24/100
9th	Bailing Biotechnology 2015, Hangzhou (China), Unfunded	Developer of antibodies for research and development	-	-	24/100
10th	Pharmamab 2010, Chieti (Italy), Funding Raised	Develops therapeutic antibodies	-	Invent Innovation Ventures	22/100